PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Excellus BlueCross BlueShieldCommercial · Coverage · Durable Medical Equipment & Supplies · NY · Pain Management, Physical Therapy, PM&R (Physical Medicine & Rehab)Medium impact

Non-Invasive Surface Electrical Stimulation for Pain and Rehabilitation 1.01.61

Effective date
May 21, 2026
Identified
Jun 20, 2026

Summary

Excellus policy 1.01.61 is a new policy with an effective date of 05/21/26, derived from policy 1.01.55, and it sets medical necessity criteria for TENS devices, including FDA approval, use for pain, symptoms lasting more than three months, failure of physical therapy, osteopathic manipulative therapy or chiropractic therapy, failure of medications, and a 30-day trial that has demonstrated efficacy. TENS is considered not medically necessary for labor and vaginal delivery pain, headaches and migraines, visceral abdominal pain, TMJ disorder, cancer pain, essential tremor, low back pain and neck pain. The policy also covers NMES for disuse muscle atrophy under listed criteria, considers FES for ambulation in spinal cord injury, stroke rehabilitation and gait training not medically necessary, and considers interferential stimulation, transcutaneous electrical joint stimulation for arthritis joint pain, and multiple modality delivery stimulation investigational.

Get alerts when payers change rules like this one

We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.

Get Excellus BlueCross BlueShield alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Already effective 05/21/26: Billing team should confirm TENS claims meet all listed criteria: FDA approval, use for the treatment of pain, symptoms persisting for more than three months, failure of physical therapy, osteopathic manipulative therapy or chiropractic therapy, failure of medications such as simple analgesics, NSAIDs or opioids, and a 30-day trial period that has demonstrated efficacy.
02Form-fitting TENS conductive garments (E0731) also require an intact nerve supply to the stimulated area and at least one of the listed garment conditions.
03NMES for disuse muscle atrophy is medically necessary only when nerve supply to the muscle is intact and the need is for non-neurological reasons, such as casting or splinting of a limb, contracture due to scarring of soft tissue as in burn lesions, or hip or knee replacement surgery, until orthotic training begins.
04Billing team should not bill TENS for the indications the policy lists as not medically necessary, and should treat E0762, S8130 and S8131 as (E/I) investigational.
05For repair of medically necessary electrical stimulation devices, physician documentation must include the date of DME initiation, manufacturer warranty information if applicable, and an attestation that the patient has been compliant with use and will continue to benefit.

Codes mentioned

A4595A4630E0720E0730E0731E0744E0745E0762E0764E0770G0283S8130S8131M53.1M53.3M54.5M62.830M79.0M79.2R52

Original notice

Non-Invasive Surface Electrical Stimulation for Pain and Rehabilitation 1.01.61
excellusbcbs.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account